These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2054754)

  • 1. Sandostatin in the management of nonendocrine gastrointestinal and pancreatic disorders: a preliminary study.
    Rosenberg L; Brown RA
    Can J Surg; 1991 Jun; 34(3):223-9. PubMed ID: 2054754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future medical prospects for Sandostatin.
    Harris AG
    Z Gastroenterol; 1990 Sep; 28 Suppl 2():55-60. PubMed ID: 1980778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis.
    Paran H; Neufeld D; Mayo A; Shwartz I; Singer P; Kaplan O; Skornik Y; Klausner J; Freund U
    J Am Coll Surg; 1995 Aug; 181(2):121-4. PubMed ID: 7627383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of external pancreatic fistulas with somatostatin. Second place winner: Conrad Jobst award.
    Lansden FT; Adams DB; Anderson MC
    Am Surg; 1989 Dec; 55(12):695-8. PubMed ID: 2574557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
    Hesse UJ; Meester D; Troisi R; Cathenis K; Lameire N; Hemptinne B
    Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial.
    Suc B; Msika S; Piccinini M; Fourtanier G; Hay JM; Flamant Y; Fingerhut A; Fagniez PL; Chipponi J;
    Arch Surg; 2004 Mar; 139(3):288-94; discussion 295. PubMed ID: 15006886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas.
    Alivizatos V; Felekis D; Zorbalas A
    Hepatogastroenterology; 2002; 49(46):1010-2. PubMed ID: 12143189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open trial of octreotide long-acting release in the management of short bowel syndrome.
    Nehra V; Camilleri M; Burton D; Oenning L; Kelly DG
    Am J Gastroenterol; 2001 May; 96(5):1494-8. PubMed ID: 11374688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide in the management of postoperative enterocutaneous fistulas and stress ulcer bleeding.
    Chen RJ; Fang JF; Chen MF
    Am J Gastroenterol; 1992 Sep; 87(9):1212-5. PubMed ID: 1519586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
    Martineau P; Shwed JA; Denis R
    Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A trial of the use of sandostatin in patients with chronic pancreatitis].
    Loginov AS; Sadokov VM; Vinokurova LV; Chernoiarova OD; Astaf'eva OV; Nilova TV
    Ter Arkh; 1995; 67(7):60-2. PubMed ID: 7482309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of somatostatin analogues in the management of enterocutaneous fistulae.
    Jamil M; Ahmed U; Sobia H
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):237-40. PubMed ID: 15228830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sandostatin treatment of destructive pancreatitis].
    Ivanov IuV
    Klin Med (Mosk); 1999; 77(9):37-9. PubMed ID: 10599225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonic complications of pancreatitis.
    Adams DB; Davis BR; Anderson MC
    Am Surg; 1994 Jan; 60(1):44-9. PubMed ID: 8273973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sandostatin treatment in postoperative external digestive fistulae].
    Munteanu D; Duca S; Vlad L; Părăian I; Togănel D; Iancu C; Pop F; Radu H; Puia C; Bălă O; Bud O; Nagy Z; Leucă D; Bordei R; Popazu R
    Chirurgia (Bucur); 1998; 93(1):13-21. PubMed ID: 9567457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Somatostatin in the treatment of pancreatic diseases].
    Németh AM
    Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsurgical management of pancreaticopleural fistula.
    Dhebri AR; Ferran N
    JOP; 2005 Mar; 6(2):152-61. PubMed ID: 15767731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of use of sandostatin in pancreatoduodenal resections].
    Skipenko OG; Voskresenskii OV; Shishlo LA; Shatverian GA; Timoshin AD; Movchun AA
    Khirurgiia (Mosk); 1997; (2):39-44. PubMed ID: 9162768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of somatostatin analogue for intestinal and pancreatic fistulas].
    Paran H; Neufeld D; Epstein T; Bendahan J; Freund U
    Harefuah; 1991 Feb; 120(4):185-6. PubMed ID: 2066018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.